.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
UBS
Colorcon
Chinese Patent Office
Argus Health
Fish and Richardson
McKesson
Cantor Fitzgerald
Dow

Generated: November 22, 2017

DrugPatentWatch Database Preview

FUROSEMIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for furosemide and what is the scope of furosemide patent protection?

Furosemide
is the generic ingredient in two branded drugs marketed by Sun Pharm Inds, Fresenius Kabi Usa, Watson Labs, Abraxis Pharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Astrazeneca, Dava Pharms Inc, Accord Hlthcare, Marsam Pharms Llc, Warner Chilcott, Smith And Nephew, West-ward Pharms Int, Intl Medication, Emcure Pharms Ltd, Watson Labs Teva, Hospira, Wockhardt, Baxter Hlthcare Corp, Sandoz, Amneal Pharms Co, Sun Pharm Inds Inc, Sanofi Aventis Us, Kalapharm, Wyeth Ayerst, Superpharm, Us Pharm Holdings, Luitpold, Mylan, Mutual Pharm, Leading Pharma Llc, Igi Labs Inc, and Prinston Inc, and is included in sixty NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for furosemide. Sixty-four suppliers are listed for this compound.

Pharmacology for FUROSEMIDE

Medical Subject Heading (MeSH) Categories for FUROSEMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
FUROSEMIDE
furosemide
TABLET;ORAL018413-002Nov 30, 1983ABRXNoNo► Subscribe► Subscribe► Subscribe
Leading Pharma Llc
FUROSEMIDE
furosemide
TABLET;ORAL077293-002Nov 9, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Intl Medication
FUROSEMIDE
furosemide
TABLET;ORAL018753-002Feb 28, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Intl Medication
FUROSEMIDE
furosemide
TABLET;ORAL018753-001Feb 28, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
FUROSEMIDE
furosemide
TABLET;ORAL018569-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
FUROSEMIDE
furosemide
TABLET;ORAL018413-001Nov 30, 1983ABRXNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
LASIX
furosemide
INJECTABLE;INJECTION016363-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Luitpold
FUROSEMIDE
furosemide
INJECTABLE;INJECTION018579-001Nov 30, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
Wockhardt
FUROSEMIDE
furosemide
SOLUTION;ORAL070655-001Oct 2, 1987AARXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
FUROSEMIDE
furosemide
TABLET;ORAL071594-001Feb 9, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: furosemide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
LASIX
furosemide
INJECTABLE;INJECTION016363-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis Us
LASIX
furosemide
SOLUTION;ORAL017688-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cerilliant
Citi
Novartis
Chinese Patent Office
Federal Trade Commission
Fuji
Harvard Business School
Argus Health
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot